Skip to main content
Critical Care logoLink to Critical Care
. 2006 Mar 21;10(Suppl 1):P340. doi: 10.1186/cc4687

Continuous central venous oxygenation measurement by CeVOX in patients undergoing off-pump coronary artery bypass grafting

C Hofer 1, M Ganter 2, P Fodor 1, R Tavakoli 1, M Genoni 3, A Zollinger 1
PMCID: PMC4092715

Introduction

Less invasive measurement of central venous O2 saturation(ScvO2) has shown to be a valuable alternative to the determination of mixed venous O2 saturation for monitoring of O2 supply/demand [1,2]. The aim of this study was to compare ScvO2 measured continuously by the new CeVOX (Pulsion Medical System, Munich, Germany) device (CScvO2) with ScvO2 determined by blood gas co-oximetry (BScvO2).

Methods

Ten ASA III patients undergoing elective off-pump coronary artery bypass grafting were studied during the operation (OP) and during their ICU stay. In addition to the standard hemodynamic monitoring according to institutional policy, a CeVOX fiber-optic probe was introduced into a standard central venous catheter placed via internal jugular vein access. OP and ICU measurement started after in-vivo calibration of CeVOX. BScvO2 and CScvO2 readings were recorded at intervals of 30 min during OP and of 120 min during ICU. Data were statistically analyzed using Bland-Altman analysis, Pearson correlation and t test for the periods during OP, ICU, a set of three consecutive measurements during OP immediately after calibration (OPcal) and 4 hours later (OP4h) as well as immediately after calibration on the ICU (ICUcal) and 14 hours later (ICU14h). Trend analysis was performed, calculating differences (Δ) between consecutive measurements. P < 0.05 was considered significant.

Results

One hundred and twenty-nine matched sets of data were obtained (OP:n = 78, ICU: n = 51) with a wide range of ScvO2 values (BScvO2 = 48.0–91.0%, CScvO2 = 49.0–94.0%). The OP observation time was 4.0–6.5 hours and the ICU measurement sequence was 14.0–20.0 hours. Bland-Altman analysis revealed an overall mean bias ± 2SD (limits of agreement) of-0.7 ± 7.8% for CScvO2 – BScvO2 during OP and -1.1± 11.6% during ICU (Fig. 1). There was no significant difference between CScvO2 and BScvO2 (OP: P = 0.120, ICU: P = 0.167). The correlation coefficient(r2) for CScvO2 vs BScvO2 was 0.885 (OP) and0.592 (ICU). Statistics for OPcal' OP4h and ICUcal were comparable, whereas for ICU14h the bias ± 2SD increased and r2 decreased (Table 1). Trend analysis showed no significant difference (OP: ΔBScvO2 = -1.3 ± 9.0%, ΔCScvO2 = -1.1 ± 8.6%, P = 0.663; ICU: ΔBScvO2 = -0.4 ± 6.8%, ΔBScvO2 = -0.4 ± 5.8%, P = 0.828).

Figure 1.

Figure 1

Table 1.

OPcal OP4h ICUcal ICU14h
Mean bias ± 2SD (%) -0.3 ± 7.2 -0.1 ± 8.4 -0.7 ± 8.6 -1.9 ± 14.0
r2 0.849 0.853 0.832 0.358

Conclusion

These preliminary results indicate that ScvO2 can be reliably assessed by CeVOX. Scheduled recalibration at intervals <14 hours may be mandatory.

References

  1. Respiration. 2001. pp. 279–285. [DOI]
  2. Acta Anaesthesiol Scand. 1998. pp. 172–177. [DOI] [PubMed]

Articles from Critical Care are provided here courtesy of BMC

RESOURCES